Hirotoshi Utsunomiya Selected Research

Hirotoshi Utsunomiya Research Topics

Disease

17	Neoplasms (Cancer) 06/2014 - 01/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 08/2013 - 11/2002
6	Hypertension (High Blood Pressure) 01/2023 - 09/2005
6	Infections 04/2022 - 01/2007
6	Insulin Resistance 11/2018 - 10/2005
6	Atherosclerosis 08/2013 - 09/2005
5	Vascular Remodeling 01/2023 - 11/2002
5	Stomach Neoplasms (Stomach Cancer) 12/2012 - 08/2005
5	Inflammation (Inflammations) 12/2012 - 08/2005
3	Fatty Liver 10/2019 - 08/2012
3	Type 2 Diabetes Mellitus (MODY) 10/2019 - 02/2007
3	Hyperglycemia 10/2019 - 05/2009
3	Atrophy 03/2014 - 04/2008
3	Gastritis 03/2014 - 03/2010
3	Breast Neoplasms (Breast Cancer) 10/2010 - 01/2002
2	Obesity 11/2018 - 05/2009
2	Hyperlipidemias (Hyperlipidemia) 01/2014 - 02/2007
2	Fibrosis (Cirrhosis) 08/2012 - 09/2005
2	Adenocarcinoma 07/2012 - 10/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2012 - 11/2005
2	Hypertrophy 05/2011 - 10/2005
2	Neoplasm Metastasis (Metastasis) 10/2010 - 11/2005
2	Carcinoma (Carcinomatosis) 10/2010 - 03/2009
2	Liver Diseases (Liver Disease) 10/2008 - 05/2007
2	Carcinogenesis 11/2007 - 08/2005
2	Cholestasis 07/2007 - 05/2007
2	Vascular System Injuries 01/2006 - 10/2005
1	Hyperplasia 04/2022
1	Food Hypersensitivity (Food Allergy) 04/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2022
1	Anaphylaxis (Anaphylactic Shock) 10/2020
1	Hypersensitivity (Allergy) 10/2020
1	Osteoporosis 10/2019
1	Gastroesophageal Reflux (GERD) 07/2015
1	Poliomyelitis (Polio) 10/2014
1	Female Infertility 06/2014
1	Diabetes Mellitus 01/2014
1	Cholecystitis 01/2012
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

6	Pepsinogen A (Pepsinogen)IBA 03/2014 - 04/2008
5	Angiotensin IIIBA 01/2023 - 10/2005
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2014
4	Indicators and Reagents (Reagents)IBA 10/2014 - 10/2002
4	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2009 - 11/2002
3	Insulin (Novolin)FDA Link 10/2019 - 01/2006
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2019 - 11/2018
2	AdiponectinIBA 11/2018 - 10/2005
2	LipidsIBA 11/2018 - 01/2014
2	AcidsIBA 07/2015 - 08/2009
2	Antiviral Agents (Antivirals)IBA 10/2014 - 04/2007
2	Estradiol (Delestrogen)FDA LinkGeneric 06/2014 - 05/2008
2	colestimideIBA 01/2014 - 02/2007
2	ErbB Receptors (EGF Receptor)IBA 08/2013 - 12/2002
2	ethyl acetateIBA 08/2013 - 05/2011
2	Fluorouracil (Carac)FDA LinkGeneric 07/2012 - 01/2002
2	Death-Associated Protein KinasesIBA 07/2012 - 04/2012
2	Etodolac (Lodine)FDA LinkGeneric 03/2010 - 08/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2010 - 08/2005
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2008 - 05/2008
2	Multidrug Resistance-Associated Protein 2IBA 05/2007 - 12/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2005 - 11/2002
2	LigandsIBA 09/2004 - 11/2002
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	Inositol (Myoinositol)IBA 01/2023
1	Immunoglobulin E (IgE)IBA 10/2020
1	Triglycerides (Triacylglycerol)IBA 10/2019
1	elcatoninIBA 10/2019
1	Teriparatide (Parathar)FDA Link 10/2019
1	Diphosphonates (Bisphosphonates)IBA 10/2019
1	Bone Density Conservation AgentsIBA 10/2019
1	Risedronic Acid (Actonel)FDA LinkGeneric 10/2019
1	Glucagon (Glukagon)FDA Link 10/2019
1	caffeic acidIBA 10/2014
1	protocatechualdehydeIBA 06/2014
1	Myosin-Light-Chain PhosphataseIBA 08/2013
1	Hormones (Hormone)IBA 08/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2013
1	IronIBA 08/2012
1	Decitabine FDA Link 04/2012
1	Heavy MetalsIBA 01/2012
1	ArsenicIBA 01/2012
1	ChromiumIBA 01/2012
1	ElementsIBA 01/2012
1	CarbohydratesIBA 10/2010
1	GlycosaminoglycansIBA 10/2010
1	Monoclonal AntibodiesIBA 10/2010
1	EpitopesIBA 10/2010
1	Polysaccharides (Glycans)IBA 10/2010
1	Biomarkers (Surrogate Marker)IBA 10/2010
1	AntigensIBA 10/2010
1	Heparitin Sulfate (Heparan Sulfate)IBA 10/2010
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2010
1	Detergents (Detergent)IBA 03/2010

Therapy/Procedure

4	Therapeutics 06/2014 - 10/2002
2	Glycemic Control 01/2014 - 02/2007
2	Chemoprevention 03/2010 - 08/2005
2	Combination Drug Therapy (Combination Chemotherapy) 05/2008 - 05/2008
1	Gastrectomy 04/2022
1	Oral Administration 10/2020